Literature DB >> 17999197

Targeted disruption of the galanin gene attenuates inflammatory responses in murine skin.

Sabine M Schmidhuber1, Anna Starr, David Wynick, Barbara Kofler, Susan D Brain.   

Abstract

The release of neuropeptides from primary sensory nerve fibers has been implicated in the modulation of local immune responses in surface tissues, such as the skin and the gastrointestinal mucosa, thereby inducing neurogenic inflammation, which is characterized by plasma extravasation and vasodilatation. In addition, cytokines, either alone or in conjunction with neuropeptides, initiate recruitment of immunocompetent cells such as neutrophils during the initial phases of inflammation. Growing evidence suggests that the neuropeptide galanin plays an important role in skin immune defense and pathophysiology. In this paper, we report that adult mice carrying a loss-of-function mutation in the galanin gene (galanin knockout, Gal KO) demonstrate an absence of the normal neurogenic inflammatory response, upon treatment of the skin either with the vanilloid receptor 1 agonist capsaicin or noxious heat. Furthermore, a lack of an acute inflammatory edema induced by coinjection of substance P and calcitonin gene-related peptide was observed. In addition, Gal KO animals also exhibit a deficit in neutrophil accumulation in the skin after exposure to noxious heat, carrageenin, or tumor necrosis factor alpha. These data indicate that Gal KO mice demonstrate abnormal neurogenic inflammatory responses in murine skin compared to strain-matched wild-type mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17999197     DOI: 10.1007/s12031-007-9015-9

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  32 in total

Review 1.  Cellular mechanisms of neurogenic inflammation.

Authors:  Jennelle Durnett Richardson; Michael R Vasko
Journal:  J Pharmacol Exp Ther       Date:  2002-09       Impact factor: 4.030

2.  Spantide II, a novel tachykinin antagonist, and galanin inhibit plasma extravasation induced by antidromic C-fiber stimulation in rat hindpaw.

Authors:  X J Xu; J X Hao; Z Wiesenfeld-Hallin; R Håkanson; K Folkers; T Hökfelt
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

3.  Growth hormone release in man induced by galanin, a new hypothalamic peptide.

Authors:  F E Bauer; L Ginsberg; M Venetikou; D J MacKay; J M Burrin; S R Bloom
Journal:  Lancet       Date:  1986-07-26       Impact factor: 79.321

4.  Use of NK(1) knockout mice to analyze substance P-induced edema formation.

Authors:  T Cao; N P Gerard; S D Brain
Journal:  Am J Physiol       Date:  1999-08

Review 5.  Sensory neuropeptides: their role in inflammation and wound healing.

Authors:  S D Brain
Journal:  Immunopharmacology       Date:  1997-10

Review 6.  Neuropeptides and their receptors: innovative science providing novel therapeutic targets.

Authors:  Susan D Brain; Helen M Cox
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

7.  Generation and phenotypic characterization of a galanin overexpressing mouse.

Authors:  K Holmberg; E Kuteeva; P Brumovsky; U Kahl; H Karlström; G A Lucas; J Rodriguez; H Westerblad; S Hilke; E Theodorsson; O-G Berge; U Lendahl; T Bartfai; T Hökfelt
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

Review 8.  Nitric oxide, inflammation and acute burn injury.

Authors:  Andrew Rawlingson
Journal:  Burns       Date:  2003-11       Impact factor: 2.744

9.  Reduction of burn injury by inhibiting CD18-mediated leukocyte adherence in rabbits.

Authors:  L P Bucky; N B Vedder; H Z Hong; H P Ehrlich; R K Winn; J M Harlan; J W May
Journal:  Plast Reconstr Surg       Date:  1994-06       Impact factor: 4.730

10.  Galanin regulates prolactin release and lactotroph proliferation.

Authors:  D Wynick; C J Small; A Bacon; F E Holmes; M Norman; C J Ormandy; E Kilic; N C Kerr; M Ghatei; F Talamantes; S R Bloom; V Pachnis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

View more
  3 in total

Review 1.  Neuropeptide receptors as potential drug targets in the treatment of inflammatory conditions.

Authors:  Erika Pintér; Gábor Pozsgai; Zsófia Hajna; Zsuzsanna Helyes; János Szolcsányi
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

2.  Octreotide negates the benefit of galantide when used in the treatment of caerulein-induced acute pancreatitis in mice.

Authors:  Savio G Barreto; Colin J Carati; Ann C Schloithe; James Toouli; Gino T P Saccone
Journal:  HPB (Oxford)       Date:  2010-08       Impact factor: 3.647

3.  Lack of Galanin 3 Receptor Aggravates Murine Autoimmune Arthritis.

Authors:  Bálint Botz; Ágnes Kemény; Susanne M Brunner; Felix Sternberg; Janka Csepregi; Attila Mócsai; Erika Pintér; Jason J McDougall; Barbara Kofler; Zsuzsanna Helyes
Journal:  J Mol Neurosci       Date:  2016-03-03       Impact factor: 2.866

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.